Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15122064rdf:typepubmed:Citationlld:pubmed
pubmed-article:15122064lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15122064lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:15122064lifeskim:mentionsumls-concept:C0022658lld:lifeskim
pubmed-article:15122064lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:15122064lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:15122064lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:15122064pubmed:issue4lld:pubmed
pubmed-article:15122064pubmed:dateCreated2004-5-3lld:pubmed
pubmed-article:15122064pubmed:abstractTextMortality among RA patients and controls was analyzed with special attention to renal disease in population-based material (originally screened in 1988) of 604 patients with RA (470 females, 134 males) and 457 age- and sex-matched controls (352 females, 105 males). In the original RA population, isolated hematuria (HU) was observed in 54, isolated proteinuria (PU) in 27, combined hematuria and proteinuria (HUPU) in 7, chronic renal failure (CRFtot) in 36 and isolated chronic renal failure without HU or PU (CRFisol) in 15 patients. Among the controls, HU was observed in 39, PU in 11, CRFtot in 32 and CRFisol in 16 subjects. HUPU was not observed in any of the controls. Microalbuminuria (20-200 microg/min) was observed in 34 RA patients and in 27 controls. Histologically confirmed amyloidosis was found in 13 RA patients and mesangial glomerulonephritis (MesGN) in 17 patients. The mortality was evaluated in 1999 from data of the Statistical Office of Finland. Statistical analysis was performed by Cox regression analysis.lld:pubmed
pubmed-article:15122064pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15122064pubmed:languageenglld:pubmed
pubmed-article:15122064pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15122064pubmed:citationSubsetIMlld:pubmed
pubmed-article:15122064pubmed:statusMEDLINElld:pubmed
pubmed-article:15122064pubmed:issn1660-2110lld:pubmed
pubmed-article:15122064pubmed:authorpubmed-author:PasternackAAlld:pubmed
pubmed-article:15122064pubmed:authorpubmed-author:LaippalaPPlld:pubmed
pubmed-article:15122064pubmed:authorpubmed-author:MustonenJJlld:pubmed
pubmed-article:15122064pubmed:authorpubmed-author:KorpelaMMlld:pubmed
pubmed-article:15122064pubmed:authorpubmed-author:SihvonenSSlld:pubmed
pubmed-article:15122064pubmed:copyrightInfoCopyright 2004 S. Karger AG, Basellld:pubmed
pubmed-article:15122064pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15122064pubmed:volume96lld:pubmed
pubmed-article:15122064pubmed:ownerNLMlld:pubmed
pubmed-article:15122064pubmed:authorsCompleteYlld:pubmed
pubmed-article:15122064pubmed:paginationc107-14lld:pubmed
pubmed-article:15122064pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:meshHeadingpubmed-meshheading:15122064...lld:pubmed
pubmed-article:15122064pubmed:year2004lld:pubmed
pubmed-article:15122064pubmed:articleTitleRenal disease as a predictor of increased mortality among patients with rheumatoid arthritis.lld:pubmed
pubmed-article:15122064pubmed:affiliationDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland. susanna.sihvonen@fimnet.filld:pubmed
pubmed-article:15122064pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15122064lld:pubmed